The 13th international Workshop on KSHV and Related Agents

简介(申请人提供)：第13届卡波西肉瘤相关疱疹病毒(KSHV)及相关药物国际研讨会自1998年起每年举办一次。这次研讨会是介绍和交流KSHV和相关代理进展的主要论坛。特别强调介绍和讨论未发表的新数据，目的是促进新研究成果、想法和发展在代表基础、翻译和临床研究的国际科学家小组之间的传播和交流，这些科学家涵盖了广泛的学科，并专注于KSHV和相关药物。这些研究的长期目标是加深我们对KSHV及其相关因子在发病机制中的作用的理解，并将这些来自不同研究领域的新知识整合到识别和开发新的治疗、预防和疫苗接种策略中，以缓解KSHV相关疾病。 本次研讨会将由加州大学洛杉矶分校(UCLA)和加州纳米系统研究所(CNSI)主办，将于2010年8月29日至9月1日在加州大学洛杉矶分校的CNSI举行，并在校园内或加州大学洛杉矶分校韦斯特伍德村内提供住宿。本次会议的剩余费用将从与会者支付的注册费以及基金会、商业、制药和生物技术公司的捐款中收回。 研讨会的科学计划将包括15分钟的演讲(10-12分钟的演讲，3分钟的问题/答案)，从九个科学会议(临床应用、细胞信号、流行病学、基因表达、宿主相互作用、潜伏期、裂解复制和结构、病毒致病机制)中提交的摘要中挑选出来。在研讨会结束时，还分配了一些时间用于后期断路器摘要和圆桌讨论。预计在为期4天的会议期间，将有大约74个平台介绍和多达60张海报。 与公共卫生相关：这项提案要求为一次年度会议(自1998年以来举行)提供部分资金，在会上介绍和交流KSHV和相关药物的研究进展，从而促进相关疾病的预防和治疗。

DESCRIPTION (provided by applicant): The 13th International Workshop on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) and Related Agents has been held annually since 1998. This workshop is the premier forum for the presentation and exchange of advances in KSHV and related agents. Special emphasis has always been on the presentation and discussion of unpublished new data with the goal to facilitate the dissemination and exchange of new research findings, ideas, and developments among an international group of scientists representing basic, translational, and clinical research who cover a broad spectrum of disciplines and focus on KSHV and related agents. The long-term goal of these studies is to enhance our understanding on how KSHV and related agents contribute to pathogenesis and to integrate this new knowledge from different research fields into the identification and development of new treatment, prevention, and vaccination strategies to alleviate KSHV associated diseases. This workshop will be hosted by the University of California, Los Angeles (UCLA) and the California NanoSystems Institute (CNSI), and will be held August 29- September 1, 2010 at CNSI on the UCLA campus with housing accommodations on campus or within the UCLA Westwood Village. The remaining costs for this conference will be recovered from registration fees paid by conferees and contributions from foundations, and commercial, pharmaceutical and biotechnology companies. The Scientific Program of the workshop will be composed of 15 minute presentations (10-12 minute talks with 3 minutes for questions/answers) chosen from abstracts submitted for scientific presentations in each of the nine Scientific Sessions (Clinical applications, Cell signaling, Epidemiology, Gene expression, Host Interactions, Latency, Lytic Replication and Structure, Viral Pathogenesis). There is also time allotted at the end of the workshop for Late Breaker abstracts and Roundtable Discussion. It is anticipated that there will be approximately 74 platform presentations and up to 60 posters presented during this 4 day meeting. PUBLIC HEALTH RELEVANCE: This proposal requests partial funding for an annual meeting (held since 1998) where there are presentations and exchange of advances in research on KSHV and related agents, thereby promote the prevention and therapy of the related diseases.